Urinary Antigen Assay Detects Legionella
|
By LabMedica International staff writers Posted on 16 Feb 2012 |
|
An antigen test had been evaluated for its ability to diagnose Legionnaires’ disease (LD) using urine samples.
Laboratory diagnosis of Legionella pneumophila infections in patients with pneumonia is based on culture, serological testing, molecular testing, and detection of soluble L. pneumophila antigen in urine.
Scientists at the Regional Laboratory of Public Health (Haarlem, The Netherlands) tested frozen urine samples from a well-described sample of patients with and without LD. Urine samples were collected between 1997 and 2010 and were stored at -70 °C until processing was performed. These included 58 urine samples from 58 patients with LD. The specificity of the test was determined by using urine samples collected from 38 patients with respiratory tract infections other than Legionella infections.
The SD Bioline Legionella Urinary Antigen test (Standard Diagnostics Inc., Kyonggi-do, Korea) was compared with those obtained by the BinaxNOW Legionella Urinary Antigen enzyme immunoassay (EIA) (Galway, Ireland). A total of 96 samples were tested with the SD Bioline and BinaxNOW test. SD Bioline test was positive for 46/58 samples with sensitivity of the assay estimated as 79%. The BinaxNOW urinary antigen test was positive 47/58, with a sensitivity of 81%. These results were obtained after 15 minutes of incubation. The difference in sensitivity between SD Bioline test and BinaxNOW is comparable. Both tests were negative in the 38 samples from the non-Legionella patients giving a specificity of 100% for both assays.
LD is an acute pneumonia caused by Legionella species, which are non-spore-forming Gram-negative rods. L. pneumophila serogroup 1 accounts for more than 90% of human infections and is the most important etiological agent of LD. It is estimated that 8,000-18,000 cases of Legionnaires' disease occur in the USA each year. The authors concluded that the findings of the evaluation indicate that the SD Bioline test is both sensitive and specific and could be a good alternative for the detection of L. pneumophila serogroup 1 antigen in urine from patients suspected of having LD. The study was published in the January 2012 edition of the Journal of Infection.
Related Links:
Regional Laboratory of Public Health
Standard Diagnostics Inc.
BinaxNOW
Laboratory diagnosis of Legionella pneumophila infections in patients with pneumonia is based on culture, serological testing, molecular testing, and detection of soluble L. pneumophila antigen in urine.
Scientists at the Regional Laboratory of Public Health (Haarlem, The Netherlands) tested frozen urine samples from a well-described sample of patients with and without LD. Urine samples were collected between 1997 and 2010 and were stored at -70 °C until processing was performed. These included 58 urine samples from 58 patients with LD. The specificity of the test was determined by using urine samples collected from 38 patients with respiratory tract infections other than Legionella infections.
The SD Bioline Legionella Urinary Antigen test (Standard Diagnostics Inc., Kyonggi-do, Korea) was compared with those obtained by the BinaxNOW Legionella Urinary Antigen enzyme immunoassay (EIA) (Galway, Ireland). A total of 96 samples were tested with the SD Bioline and BinaxNOW test. SD Bioline test was positive for 46/58 samples with sensitivity of the assay estimated as 79%. The BinaxNOW urinary antigen test was positive 47/58, with a sensitivity of 81%. These results were obtained after 15 minutes of incubation. The difference in sensitivity between SD Bioline test and BinaxNOW is comparable. Both tests were negative in the 38 samples from the non-Legionella patients giving a specificity of 100% for both assays.
LD is an acute pneumonia caused by Legionella species, which are non-spore-forming Gram-negative rods. L. pneumophila serogroup 1 accounts for more than 90% of human infections and is the most important etiological agent of LD. It is estimated that 8,000-18,000 cases of Legionnaires' disease occur in the USA each year. The authors concluded that the findings of the evaluation indicate that the SD Bioline test is both sensitive and specific and could be a good alternative for the detection of L. pneumophila serogroup 1 antigen in urine from patients suspected of having LD. The study was published in the January 2012 edition of the Journal of Infection.
Related Links:
Regional Laboratory of Public Health
Standard Diagnostics Inc.
BinaxNOW
New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
New
Luteinizing Hormone Assay
DRG LH-Serum ELISA Kit
New
Chlamydia Trachomatis Assay
Chlamydia Trachomatis IgG
Latest Microbiology News
- Molecular Stool Test Shows Potential for Diagnosing TB in Adults with HIV
- New Test Diagnoses Bacterial Meningitis Quickly and Accurately
- Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
- New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
- Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
- Innovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
- Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
- Rapid PCR Testing in ICU Improves Antibiotic Stewardship
- Unique Genetic Signature Predicts Drug Resistance in Bacteria
- Unique Barcoding System Tracks Pneumonia-Causing Bacteria as They Infect Blood Stream
- Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application
- Rapid Diagnostic System to Detect Neonatal Sepsis Within Hours
- Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood
- Interferon-γ Release Assay Effective in Patients with COPD Complicated with Pulmonary Tuberculosis
- New Point of Care Tests to Help Reduce Overuse of Antibiotics
- 30-Minute Sepsis Test Differentiates Bacterial Infections, Viral Infections, and Noninfectious Disease
Channels
Clinical Chemistry
view channel
AI-Powered Blood Test Accurately Detects Ovarian Cancer
Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more
Automated Decentralized cfDNA NGS Assay Identifies Alterations in Advanced Solid Tumors
Current circulating cell-free DNA (cfDNA) assays are typically centralized, requiring specialized handling and transportation of samples. Introducing a flexible, decentralized sequencing system at the... Read more
Mass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication
Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more
First Comprehensive Syphilis Test to Definitively Diagnose Active Infection In 10 Minutes
In the United States, syphilis cases have surged by nearly 80% from 2018 to 2023, with 209,253 cases recorded in the most recent year of data. Syphilis, which can be transmitted sexually or from mother... Read moreMolecular Diagnostics
view channel
Microbial Cell-Free DNA Test Accurately Identifies Pathogens Causing Pneumonia and Other Lung Infections
Bronchoalveolar lavage (BAL) is a commonly used procedure for diagnosing lung infections, especially in immunocompromised patients. However, standard tests often fail to pinpoint the exact pathogen, leading... Read more
Non-Biopsy Approach to Transform Adult Celiac Disease Diagnoses
In the United States, the diagnosis of celiac disease in adults typically relies on a combination of serologic testing and a confirmatory small bowel biopsy during upper endoscopy. In contrast, European... Read more
Hematology
view channel
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read more
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Immunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Pathology
view channel
Groundbreaking Chest Pain Triage Algorithm to Transform Cardiac Care
Cardiovascular disease is responsible for a third of all deaths worldwide, and chest pain is the second most common reason for emergency department (ED) visits. With EDs often being some of the busiest... Read more
AI-Based Liquid Biopsy Approach to Revolutionize Brain Cancer Detection
Detecting brain cancers remains extremely challenging, with many patients only receiving a diagnosis at later stages after symptoms like headaches, seizures, or cognitive issues appear. Late-stage diagnoses... Read more
Technology
view channel
Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more
